1. Home
  2. NNOX vs WHWK Comparison

NNOX vs WHWK Comparison

Compare NNOX & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NANO-X IMAGING LTD

NNOX

NANO-X IMAGING LTD

HOLD

Current Price

$2.21

Market Cap

155.6M

Sector

Health Care

ML Signal

HOLD

WHWK

Whitehawk Therapeutics Inc.

HOLD

Current Price

$3.16

Market Cap

179.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNOX
WHWK
Founded
2011
2007
Country
Israel
United States
Employees
N/A
22
Industry
Medical Electronics
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.6M
179.8M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
NNOX
WHWK
Price
$2.21
$3.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$7.00
$7.00
AVG Volume (30 Days)
593.1K
176.9K
Earning Date
03-31-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.19
N/A
Revenue Next Year
$137.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.11
$1.39
52 Week High
$5.72
$4.40

Technical Indicators

Market Signals
Indicator
NNOX
WHWK
Relative Strength Index (RSI) 32.56 39.62
Support Level $2.11 $1.84
Resistance Level $2.75 $3.77
Average True Range (ATR) 0.12 0.26
MACD -0.03 -0.09
Stochastic Oscillator 6.36 0.83

Price Performance

Historical Comparison
NNOX
WHWK

About NNOX NANO-X IMAGING LTD

Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.

About WHWK Whitehawk Therapeutics Inc.

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Share on Social Networks: